Skip to main content
Oncolys BioPharma Inc. logo

Oncolys BioPharma Inc. — Investor Relations & Filings

Ticker · 4588 ISIN · JP3202170001 T Manufacturing
Open in API
Filings indexed 83 across all filing types
Latest filing 2022-03-31 Governance Information
Country JP Japan
Listing T 4588

About Oncolys BioPharma Inc.

https://www.oncolys.com/en/

Oncolys BioPharma Inc. is a biopharmaceutical company focused on the research and development of breakthrough therapies and diagnostics for cancer. The company's core technology is oncolytic virotherapy, which utilizes viruses to selectively target and destroy cancer cells. Its development pipeline addresses multiple stages of cancer care, spanning from early detection and prognostic testing to loco-regional and systemic treatments. The company aims to develop innovative and effective drugs to meet the needs of patients and healthcare providers in the field of oncology.

Recent filings

Filing Released Lang Actions
内部統制報告書－第18期(令和3年1月1日－令和3年12月31日)
Governance Information Classification · 100% confidence The document is titled '内部統制報告書' (Internal Control Report) and cites the Financial Instruments and Exchange Act (Article 24-4-4, Paragraph 1). It details the framework, scope, and results of the company's internal control over financial reporting. This type of standalone regulatory filing regarding internal controls falls under the 'Audit Report / Information' category as it pertains to audit-related compliance and internal control assessments.
2022-03-31 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO and CFO regarding the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). Since this is a standalone regulatory filing confirming the validity of financial disclosures rather than the financial report itself, and it does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing. FY 2021
2022-03-31 Japanese
有価証券報告書－第18期(令和3年1月1日－令和3年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard Japanese regulatory filing equivalent to the US 10-K, covering the fiscal year (第18期) from January 1, 2021, to December 31, 2021. It contains comprehensive financial statements, management discussion, and corporate information, fitting the definition of an Annual Report. FY 2021
2022-03-31 Japanese
四半期報告書－第18期第3四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It covers the third quarter of the 18th fiscal period (July 1, 2021, to September 30, 2021). It contains comprehensive financial statements, management analysis (MDA), and business updates, which fits the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-05 Japanese
四半期報告書－第18期第2四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis (MDA), and business updates for the second quarter of the 18th fiscal period (April 1, 2021, to June 30, 2021). This fits the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-06 Japanese
四半期報告書－第18期第1四半期(令和3年1月1日－令和3年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, covering the first quarter of the 18th fiscal period (January 1, 2021, to March 31, 2021). It contains detailed financial statements, management analysis (MDA), and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-07 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.